

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.40895681 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.40895681 |
| 3 | exogenous drug catabolic process (GO:0042738) | 7.26688634 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.07419649 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.07419649 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.73214314 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22304270 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.12774752 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.12774752 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.12774752 |
| 11 | omega-hydroxylase P450 pathway (GO:0097267) | 6.10437809 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.01312383 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.99370729 |
| 14 | epoxygenase P450 pathway (GO:0019373) | 5.83249376 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.76911752 |
| 16 | urea cycle (GO:0000050) | 5.71112851 |
| 17 | urea metabolic process (GO:0019627) | 5.71112851 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.66996123 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.63569695 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.59602800 |
| 21 | complement activation, alternative pathway (GO:0006957) | 5.51114272 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.50209186 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.47862631 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.41117237 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.37570514 |
| 26 | protein carboxylation (GO:0018214) | 5.37570514 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.24352420 |
| 28 | cysteine metabolic process (GO:0006534) | 5.17506769 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.15739316 |
| 30 | regulation of complement activation (GO:0030449) | 5.14755099 |
| 31 | bile acid metabolic process (GO:0008206) | 5.11899282 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.98844330 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.97412616 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.89167914 |
| 35 | homocysteine metabolic process (GO:0050667) | 4.87260145 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.86295204 |
| 37 | oxidative demethylation (GO:0070989) | 4.83186966 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.81226891 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.78402988 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.78402988 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.78402988 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.77030934 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.73700165 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.59377986 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.58729109 |
| 46 | phospholipid efflux (GO:0033700) | 4.58001560 |
| 47 | lysine catabolic process (GO:0006554) | 4.56509420 |
| 48 | lysine metabolic process (GO:0006553) | 4.56509420 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.53588937 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.53588937 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.51722887 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.51722887 |
| 53 | drug metabolic process (GO:0017144) | 4.48300183 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 4.43974501 |
| 55 | bile acid and bile salt transport (GO:0015721) | 4.43723432 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 4.33835701 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.32372193 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 4.31265557 |
| 59 | cholesterol efflux (GO:0033344) | 4.29030766 |
| 60 | glycine metabolic process (GO:0006544) | 4.28666746 |
| 61 | cellular glucuronidation (GO:0052695) | 4.26851713 |
| 62 | amine catabolic process (GO:0009310) | 4.25527079 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 4.25527079 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 4.24980645 |
| 65 | cellular amino acid catabolic process (GO:0009063) | 4.20882994 |
| 66 | glutamate metabolic process (GO:0006536) | 4.16019709 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 4.14661301 |
| 68 | low-density lipoprotein particle remodeling (GO:0034374) | 4.12472650 |
| 69 | negative regulation of complement activation (GO:0045916) | 4.06878678 |
| 70 | plasma lipoprotein particle assembly (GO:0034377) | 4.06377480 |
| 71 | ethanol oxidation (GO:0006069) | 4.05541154 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 4.05446672 |
| 73 | fibrinolysis (GO:0042730) | 4.04967492 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02217410 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 3.95490100 |
| 76 | arginine metabolic process (GO:0006525) | 3.92552346 |
| 77 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.92483542 |
| 78 | blood coagulation, intrinsic pathway (GO:0007597) | 3.86216460 |
| 79 | aldehyde catabolic process (GO:0046185) | 3.86178909 |
| 80 | drug catabolic process (GO:0042737) | 3.86100994 |
| 81 | positive regulation of lipid catabolic process (GO:0050996) | 3.86080572 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 3.85985898 |
| 83 | phospholipid homeostasis (GO:0055091) | 3.82615248 |
| 84 | complement activation, classical pathway (GO:0006958) | 3.80852313 |
| 85 | complement activation (GO:0006956) | 3.79551654 |
| 86 | uronic acid metabolic process (GO:0006063) | 3.78086807 |
| 87 | glucuronate metabolic process (GO:0019585) | 3.78086807 |
| 88 | cofactor catabolic process (GO:0051187) | 3.76059766 |
| 89 | protein activation cascade (GO:0072376) | 3.75951995 |
| 90 | negative regulation of lipase activity (GO:0060192) | 3.74534926 |
| 91 | ketone body metabolic process (GO:1902224) | 3.73241547 |
| 92 | cholesterol homeostasis (GO:0042632) | 3.72992524 |
| 93 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71029438 |
| 94 | acetyl-CoA metabolic process (GO:0006084) | 3.70897065 |
| 95 | organic acid catabolic process (GO:0016054) | 3.70182200 |
| 96 | carboxylic acid catabolic process (GO:0046395) | 3.70182200 |
| 97 | cytolysis (GO:0019835) | 3.69938968 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69787743 |
| 99 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69787743 |
| 100 | heme transport (GO:0015886) | 3.68374080 |
| 101 | sterol homeostasis (GO:0055092) | 3.66641836 |
| 102 | negative regulation of protein activation cascade (GO:2000258) | 3.66406234 |
| 103 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.66127106 |
| 104 | protein-lipid complex assembly (GO:0065005) | 3.64522107 |
| 105 | short-chain fatty acid metabolic process (GO:0046459) | 3.64174292 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.63882227 |
| 107 | ethanol metabolic process (GO:0006067) | 3.62785069 |
| 108 | S-adenosylmethionine metabolic process (GO:0046500) | 3.60358512 |
| 109 | flavonoid metabolic process (GO:0009812) | 3.54034425 |
| 110 | opsonization (GO:0008228) | 3.46831497 |
| 111 | phenylpropanoid metabolic process (GO:0009698) | 3.39594801 |
| 112 | regulation of humoral immune response (GO:0002920) | 3.37379262 |
| 113 | fatty acid transmembrane transport (GO:1902001) | 3.27647731 |
| 114 | alkaloid metabolic process (GO:0009820) | 3.09957715 |
| 115 | negative regulation of humoral immune response (GO:0002921) | 3.06521572 |
| 116 | negative regulation of hemostasis (GO:1900047) | 2.95690767 |
| 117 | negative regulation of blood coagulation (GO:0030195) | 2.95690767 |
| 118 | xenobiotic catabolic process (GO:0042178) | 2.91594143 |
| 119 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.81065546 |
| 120 | arginine catabolic process (GO:0006527) | 2.80035372 |
| 121 | xenobiotic metabolic process (GO:0006805) | 2.79668636 |
| 122 | regulation of plasminogen activation (GO:0010755) | 2.76302575 |
| 123 | negative regulation of coagulation (GO:0050819) | 2.71504304 |
| 124 | acute-phase response (GO:0006953) | 2.71261554 |
| 125 | sodium-independent organic anion transport (GO:0043252) | 2.69997765 |
| 126 | positive regulation of glycolytic process (GO:0045821) | 2.64590522 |
| 127 | negative regulation of wound healing (GO:0061045) | 2.64467973 |
| 128 | cellular response to ethanol (GO:0071361) | 2.64419858 |
| 129 | amino acid salvage (GO:0043102) | 2.63899105 |
| 130 | L-methionine salvage (GO:0071267) | 2.63899105 |
| 131 | L-methionine biosynthetic process (GO:0071265) | 2.63899105 |
| 132 | hormone catabolic process (GO:0042447) | 2.57754842 |
| 133 | dopamine transport (GO:0015872) | 2.57391037 |
| 134 | regulation of sarcomere organization (GO:0060297) | 2.55638836 |
| 135 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.55412598 |
| 136 | drug transmembrane transport (GO:0006855) | 2.52762777 |
| 137 | regulation of lipoprotein metabolic process (GO:0050746) | 2.52055941 |
| 138 | indole-containing compound metabolic process (GO:0042430) | 2.51407492 |
| 139 | regulation of sequestering of triglyceride (GO:0010889) | 2.50924769 |
| 140 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.48986756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.20828375 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.03457465 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.98083881 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46043897 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24930553 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.98345846 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.76996789 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.11514386 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.88744860 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14070292 |
| 11 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.26391597 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.24514603 |
| 13 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.23265750 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.11568841 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.10756400 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04751750 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7119581 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95771552 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.91965822 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87467966 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.86221542 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.80276010 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.77478369 |
| 24 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68759981 |
| 25 | STAT3_23295773_ChIP-Seq_U87_Human | 1.68399634 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67787647 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66924469 |
| 28 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66862324 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66054020 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64967738 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64368880 |
| 32 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61769580 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.58656749 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56769297 |
| 35 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53531669 |
| 36 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.52209128 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51942785 |
| 38 | TCF4_23295773_ChIP-Seq_U87_Human | 1.51753078 |
| 39 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.50548587 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48261544 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46538164 |
| 42 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45075767 |
| 43 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.44393900 |
| 44 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.43253346 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.43174958 |
| 46 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40210722 |
| 47 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36787526 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35907842 |
| 49 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35872280 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34890761 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33635442 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.33635442 |
| 53 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32200721 |
| 54 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32127316 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30850089 |
| 56 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27256006 |
| 57 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25833666 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25122092 |
| 59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.23782389 |
| 60 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23144932 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22941886 |
| 62 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22304933 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21637831 |
| 64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21576212 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21230075 |
| 66 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17828759 |
| 67 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.17468534 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16960694 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16516122 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15457032 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15266695 |
| 72 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.15164334 |
| 73 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.14891865 |
| 74 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14621797 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14520138 |
| 76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14196047 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13151139 |
| 78 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13151139 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13148159 |
| 80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12377269 |
| 81 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11583742 |
| 82 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11451603 |
| 83 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09648448 |
| 84 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08973270 |
| 85 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.08016281 |
| 86 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.05182406 |
| 87 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04725361 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04701887 |
| 89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04701887 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04438519 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03924429 |
| 92 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03876015 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03077881 |
| 94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02764567 |
| 95 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00806657 |
| 96 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00506968 |
| 97 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00415614 |
| 98 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99593886 |
| 99 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99307115 |
| 100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91581190 |
| 101 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90463538 |
| 102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90458066 |
| 103 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85880514 |
| 104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85319354 |
| 105 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84377166 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82853420 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81502865 |
| 108 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79894697 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78977357 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78315965 |
| 111 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78315965 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76392224 |
| 113 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75397331 |
| 114 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75240627 |
| 115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75009796 |
| 116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74226032 |
| 117 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72578228 |
| 118 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.72418636 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72161523 |
| 120 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68875054 |
| 121 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66563287 |
| 122 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64757919 |
| 123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61804838 |
| 124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59177019 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57359133 |
| 126 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56539939 |
| 127 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55396211 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55370421 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55226684 |
| 130 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54832157 |
| 131 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.54058226 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.53866066 |
| 133 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53426305 |
| 134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.53282660 |
| 135 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.52882846 |
| 136 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.52182197 |
| 137 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.51949077 |
| 138 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51542297 |
| 139 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50836435 |
| 140 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50621742 |
| 141 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.50166308 |
| 142 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49851890 |
| 143 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49717497 |
| 144 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.49457868 |
| 145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48618594 |
| 146 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48045966 |
| 147 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.47373679 |
| 148 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.46112535 |
| 149 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45953348 |
| 150 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.45342908 |
| 151 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.45301530 |
| 152 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44777517 |
| 153 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43848498 |
| 154 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42950953 |
| 155 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.42594048 |
| 156 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42500348 |
| 157 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41495121 |
| 158 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.41086422 |
| 159 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.40685353 |
| 160 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.40548392 |
| 161 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40121041 |
| 162 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39903515 |
| 163 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.39170018 |
| 164 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38803691 |
| 165 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38386946 |
| 166 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38371264 |
| 167 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.37960074 |
| 168 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.37264206 |
| 169 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37033653 |
| 170 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36989226 |
| 171 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35840751 |
| 172 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.35748419 |
| 173 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35137884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.33969376 |
| 2 | MP0005360_urolithiasis | 7.51340313 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.52154968 |
| 4 | MP0005365_abnormal_bile_salt | 6.26775853 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.07639808 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.21035918 |
| 7 | MP0003252_abnormal_bile_duct | 3.98926495 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58776511 |
| 9 | MP0009840_abnormal_foam_cell | 3.14898922 |
| 10 | MP0005083_abnormal_biliary_tract | 3.12787657 |
| 11 | MP0003646_muscle_fatigue | 3.06451586 |
| 12 | MP0003195_calcinosis | 2.78890542 |
| 13 | MP0005332_abnormal_amino_acid | 2.72000472 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.56802887 |
| 15 | MP0005275_abnormal_skin_tensile | 2.37869370 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.18750383 |
| 17 | MP0000609_abnormal_liver_physiology | 2.16525950 |
| 18 | MP0005503_abnormal_tendon_morphology | 2.13590085 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.11326639 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.07066762 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.02643016 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 1.96378142 |
| 23 | MP0003868_abnormal_feces_composition | 1.92335590 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 1.82598484 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.80941378 |
| 26 | MP0003045_fibrosis | 1.70944809 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.70853706 |
| 28 | MP0009697_abnormal_copulation | 1.68186779 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.67152047 |
| 30 | MP0001764_abnormal_homeostasis | 1.65492241 |
| 31 | MP0004084_abnormal_cardiac_muscle | 1.58020538 |
| 32 | MP0000751_myopathy | 1.54479704 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.54247731 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53501357 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.53449062 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.43939429 |
| 37 | MP0003011_delayed_dark_adaptation | 1.36632758 |
| 38 | MP0005451_abnormal_body_composition | 1.33010078 |
| 39 | MP0005551_abnormal_eye_electrophysiolog | 1.27098390 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.25126513 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.25094145 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.22070957 |
| 43 | MP0004272_abnormal_basement_membrane | 1.21537119 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.19058512 |
| 45 | MP0003186_abnormal_redox_activity | 1.18216331 |
| 46 | MP0000598_abnormal_liver_morphology | 1.15843346 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.15374922 |
| 48 | MP0008775_abnormal_heart_ventricle | 1.14413819 |
| 49 | MP0005647_abnormal_sex_gland | 1.14324785 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.14282519 |
| 51 | MP0000604_amyloidosis | 1.07858718 |
| 52 | MP0004484_altered_response_of | 1.07618252 |
| 53 | MP0002108_abnormal_muscle_morphology | 1.07300335 |
| 54 | MP0008004_abnormal_stomach_pH | 1.06821170 |
| 55 | MP0009764_decreased_sensitivity_to | 1.06522301 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.04373534 |
| 57 | MP0002254_reproductive_system_inflammat | 1.02439188 |
| 58 | MP0009763_increased_sensitivity_to | 1.01679499 |
| 59 | MP0010368_abnormal_lymphatic_system | 1.00064356 |
| 60 | MP0009046_muscle_twitch | 0.98531170 |
| 61 | MP0005595_abnormal_vascular_smooth | 0.98006627 |
| 62 | MP0002295_abnormal_pulmonary_circulatio | 0.95643767 |
| 63 | MP0005670_abnormal_white_adipose | 0.94521082 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 0.94195353 |
| 65 | MP0003279_aneurysm | 0.92893216 |
| 66 | MP0005620_abnormal_muscle_contractility | 0.92876351 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 0.90443316 |
| 68 | MP0001879_abnormal_lymphatic_vessel | 0.90422325 |
| 69 | MP0001986_abnormal_taste_sensitivity | 0.88627966 |
| 70 | MP0008469_abnormal_protein_level | 0.87025347 |
| 71 | MP0000749_muscle_degeneration | 0.85902080 |
| 72 | MP0009642_abnormal_blood_homeostasis | 0.85248228 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.83450822 |
| 74 | MP0005645_abnormal_hypothalamus_physiol | 0.82185010 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 0.81230328 |
| 76 | MP0001661_extended_life_span | 0.80781432 |
| 77 | MP0005408_hypopigmentation | 0.80665400 |
| 78 | MP0004130_abnormal_muscle_cell | 0.79669273 |
| 79 | MP0005646_abnormal_pituitary_gland | 0.78434414 |
| 80 | MP0005376_homeostasis/metabolism_phenot | 0.78426929 |
| 81 | MP0001958_emphysema | 0.77836036 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.77704679 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.77299036 |
| 84 | MP0006276_abnormal_autonomic_nervous | 0.76827951 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 0.76802726 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.76301805 |
| 87 | MP0001984_abnormal_olfaction | 0.76273868 |
| 88 | MP0004085_abnormal_heartbeat | 0.75647304 |
| 89 | MP0003879_abnormal_hair_cell | 0.75539855 |
| 90 | MP0003690_abnormal_glial_cell | 0.74323959 |
| 91 | MP0004142_abnormal_muscle_tone | 0.73220266 |
| 92 | MP0002971_abnormal_brown_adipose | 0.72882530 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 0.72098529 |
| 94 | MP0002933_joint_inflammation | 0.71931243 |
| 95 | MP0005334_abnormal_fat_pad | 0.71389603 |
| 96 | MP0003633_abnormal_nervous_system | 0.71116047 |
| 97 | MP0004043_abnormal_pH_regulation | 0.68297093 |
| 98 | MP0005369_muscle_phenotype | 0.67966141 |
| 99 | MP0005535_abnormal_body_temperature | 0.66943253 |
| 100 | MP0002106_abnormal_muscle_physiology | 0.66518209 |
| 101 | MP0003329_amyloid_beta_deposits | 0.64942460 |
| 102 | MP0006054_spinal_hemorrhage | 0.64675845 |
| 103 | MP0005379_endocrine/exocrine_gland_phen | 0.64140020 |
| 104 | MP0005171_absent_coat_pigmentation | 0.63776938 |
| 105 | MP0002972_abnormal_cardiac_muscle | 0.63503947 |
| 106 | MP0000372_irregular_coat_pigmentation | 0.62852343 |
| 107 | MP0005385_cardiovascular_system_phenoty | 0.62283768 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.62283768 |
| 109 | MP0005266_abnormal_metabolism | 0.61934246 |
| 110 | MP0009053_abnormal_anal_canal | 0.61218317 |
| 111 | MP0006138_congestive_heart_failure | 0.61126740 |
| 112 | MP0002269_muscular_atrophy | 0.61064324 |
| 113 | MP0000639_abnormal_adrenal_gland | 0.60838942 |
| 114 | MP0004924_abnormal_behavior | 0.60343491 |
| 115 | MP0001756_abnormal_urination | 0.57208355 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.54205590 |
| 117 | MP0005448_abnormal_energy_balance | 0.54181313 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.51626032 |
| 119 | MP0002928_abnormal_bile_duct | 0.50333555 |
| 120 | MP0002837_dystrophic_cardiac_calcinosis | 0.49072994 |
| 121 | MP0002822_catalepsy | 0.47509022 |
| 122 | MP0008874_decreased_physiological_sensi | 0.47475599 |
| 123 | MP0005395_other_phenotype | 0.46888145 |
| 124 | MP0003724_increased_susceptibility_to | 0.44566465 |
| 125 | MP0004381_abnormal_hair_follicle | 0.43485978 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.43434740 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.42622773 |
| 128 | MP0008873_increased_physiological_sensi | 0.41834943 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.41074857 |
| 130 | MP0000579_abnormal_nail_morphology | 0.41028165 |
| 131 | MP0003075_altered_response_to | 0.39721185 |
| 132 | MP0003953_abnormal_hormone_level | 0.39608385 |
| 133 | MP0005248_abnormal_Harderian_gland | 0.37128818 |
| 134 | MP0005166_decreased_susceptibility_to | 0.36933151 |
| 135 | MP0003718_maternal_effect | 0.36628617 |
| 136 | MP0009384_cardiac_valve_regurgitation | 0.36275359 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.36059144 |
| 138 | MP0003436_decreased_susceptibility_to | 0.35864662 |
| 139 | MP0002168_other_aberrant_phenotype | 0.35418280 |
| 140 | MP0001243_abnormal_dermal_layer | 0.34040122 |
| 141 | MP0008872_abnormal_physiological_respon | 0.33799232 |
| 142 | MP0004883_abnormal_blood_vessel | 0.33776120 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.33406533 |
| 144 | MP0009115_abnormal_fat_cell | 0.33108588 |
| 145 | MP0000249_abnormal_blood_vessel | 0.32725052 |
| 146 | MP0001853_heart_inflammation | 0.31365121 |
| 147 | MP0002060_abnormal_skin_morphology | 0.31292639 |
| 148 | MP0006082_CNS_inflammation | 0.29945457 |
| 149 | MP0009672_abnormal_birth_weight | 0.29851509 |
| 150 | MP0002796_impaired_skin_barrier | 0.29506658 |
| 151 | MP0002970_abnormal_white_adipose | 0.28908772 |
| 152 | MP0001881_abnormal_mammary_gland | 0.27555084 |
| 153 | MP0000427_abnormal_hair_cycle | 0.27213998 |
| 154 | MP0002090_abnormal_vision | 0.26657500 |
| 155 | MP0005164_abnormal_response_to | 0.26639572 |
| 156 | MP0001845_abnormal_inflammatory_respons | 0.25622717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.46848621 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.43525948 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.18345526 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.68772282 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.68288469 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.51867372 |
| 7 | Xanthomatosis (HP:0000991) | 6.40602975 |
| 8 | Complement deficiency (HP:0004431) | 5.61241265 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.41992200 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.85594187 |
| 11 | Joint hemorrhage (HP:0005261) | 4.83542257 |
| 12 | Epidermoid cyst (HP:0200040) | 4.79164545 |
| 13 | Hyperammonemia (HP:0001987) | 4.57657383 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.57287777 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.45435386 |
| 16 | Hyperglycinemia (HP:0002154) | 4.32220519 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.29459738 |
| 18 | Fat malabsorption (HP:0002630) | 4.25399516 |
| 19 | Ketosis (HP:0001946) | 4.22342917 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18962478 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.18667103 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11866984 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.11714345 |
| 24 | Abnormality of complement system (HP:0005339) | 4.08615626 |
| 25 | Conjugated hyperbilirubinemia (HP:0002908) | 3.87275364 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.86827050 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.81551702 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.81551702 |
| 29 | Hyperglycinuria (HP:0003108) | 3.81027525 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79244243 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78541127 |
| 32 | Fair hair (HP:0002286) | 3.77465005 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.76442682 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.34323133 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.31466151 |
| 36 | Hyperventilation (HP:0002883) | 3.26903667 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26612005 |
| 38 | Steatorrhea (HP:0002570) | 3.13274053 |
| 39 | Spontaneous abortion (HP:0005268) | 3.06364651 |
| 40 | Skin nodule (HP:0200036) | 3.03298682 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.02036539 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.00973384 |
| 43 | Myocardial infarction (HP:0001658) | 3.00668869 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00306364 |
| 45 | Ketoacidosis (HP:0001993) | 3.00017866 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.96602844 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.90164388 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.83666559 |
| 49 | Acanthocytosis (HP:0001927) | 2.80788347 |
| 50 | Generalized hypopigmentation of hair (HP:0011358) | 2.80514499 |
| 51 | Abnormality of the renal cortex (HP:0011035) | 2.70891794 |
| 52 | Mitral stenosis (HP:0001718) | 2.69573103 |
| 53 | Metabolic acidosis (HP:0001942) | 2.66459879 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.60837424 |
| 55 | Chronic hepatic failure (HP:0100626) | 2.58760370 |
| 56 | Glomerulonephritis (HP:0000099) | 2.56811696 |
| 57 | Lethargy (HP:0001254) | 2.55579344 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.54292400 |
| 59 | Vascular calcification (HP:0004934) | 2.53724748 |
| 60 | Gaze-evoked nystagmus (HP:0000640) | 2.53605550 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.50076797 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.48282337 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48282337 |
| 64 | Abnormal biliary tract physiology (HP:0012439) | 2.46717966 |
| 65 | Bile duct proliferation (HP:0001408) | 2.46717966 |
| 66 | Cerebral edema (HP:0002181) | 2.44041627 |
| 67 | Cholelithiasis (HP:0001081) | 2.43823562 |
| 68 | Spastic diplegia (HP:0001264) | 2.41753710 |
| 69 | Keratoconus (HP:0000563) | 2.40756049 |
| 70 | Increased corneal curvature (HP:0100692) | 2.40756049 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40153228 |
| 72 | Cholecystitis (HP:0001082) | 2.38381870 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 2.38381870 |
| 74 | Pancreatic cysts (HP:0001737) | 2.37074344 |
| 75 | Amyloidosis (HP:0011034) | 2.32197929 |
| 76 | Neonatal onset (HP:0003623) | 2.31931699 |
| 77 | Hematochezia (HP:0002573) | 2.31916249 |
| 78 | Irritability (HP:0000737) | 2.31508301 |
| 79 | Gout (HP:0001997) | 2.31343142 |
| 80 | Blue irides (HP:0000635) | 2.30139954 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.29613533 |
| 82 | Gingival bleeding (HP:0000225) | 2.27102607 |
| 83 | Esophageal varix (HP:0002040) | 2.22527878 |
| 84 | Potter facies (HP:0002009) | 2.19096274 |
| 85 | Facial shape deformation (HP:0011334) | 2.19096274 |
| 86 | Congenital sensorineural hearing impairment (HP:0008527) | 2.16807660 |
| 87 | Malnutrition (HP:0004395) | 2.16344550 |
| 88 | Calf muscle hypertrophy (HP:0008981) | 2.13665365 |
| 89 | Bundle branch block (HP:0011710) | 2.13061384 |
| 90 | Sensorimotor neuropathy (HP:0007141) | 2.11746465 |
| 91 | Striae distensae (HP:0001065) | 2.11505612 |
| 92 | Attenuation of retinal blood vessels (HP:0007843) | 2.11498907 |
| 93 | Menorrhagia (HP:0000132) | 2.11447262 |
| 94 | Pancreatitis (HP:0001733) | 2.11063789 |
| 95 | Late onset (HP:0003584) | 2.10761584 |
| 96 | Enlarged kidneys (HP:0000105) | 2.09453644 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09336079 |
| 98 | Congenital stationary night blindness (HP:0007642) | 2.09266628 |
| 99 | Poikilocytosis (HP:0004447) | 2.09063955 |
| 100 | Brushfield spots (HP:0001088) | 2.06451007 |
| 101 | Thrombophlebitis (HP:0004418) | 2.05790140 |
| 102 | Portal hypertension (HP:0001409) | 2.03906231 |
| 103 | Tubular atrophy (HP:0000092) | 2.02669150 |
| 104 | Pancreatic fibrosis (HP:0100732) | 2.00525059 |
| 105 | Vomiting (HP:0002013) | 2.00153327 |
| 106 | Hemorrhage of the eye (HP:0011885) | 2.00143966 |
| 107 | Abnormality of the gallbladder (HP:0005264) | 1.99546426 |
| 108 | Wrist flexion contracture (HP:0001239) | 1.96485416 |
| 109 | Progressive cerebellar ataxia (HP:0002073) | 1.96308154 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 1.96199403 |
| 111 | Generalized aminoaciduria (HP:0002909) | 1.95755239 |
| 112 | Pigmentary retinal degeneration (HP:0001146) | 1.95422335 |
| 113 | Genetic anticipation (HP:0003743) | 1.94535639 |
| 114 | Nephronophthisis (HP:0000090) | 1.94169004 |
| 115 | Abnormality of the renal medulla (HP:0100957) | 1.93739644 |
| 116 | Opisthotonus (HP:0002179) | 1.93090793 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91990782 |
| 118 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.91203291 |
| 119 | Rickets (HP:0002748) | 1.90977859 |
| 120 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.89861040 |
| 121 | Heart block (HP:0012722) | 1.89475501 |
| 122 | Congenital hepatic fibrosis (HP:0002612) | 1.89281326 |
| 123 | Aortic aneurysm (HP:0004942) | 1.89071818 |
| 124 | Thyroiditis (HP:0100646) | 1.88415127 |
| 125 | Tubulointerstitial fibrosis (HP:0005576) | 1.87915766 |
| 126 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84904623 |
| 127 | Abnormality of alanine metabolism (HP:0010916) | 1.84904623 |
| 128 | Hyperalaninemia (HP:0003348) | 1.84904623 |
| 129 | Nephritis (HP:0000123) | 1.84752507 |
| 130 | Hyperglycemia (HP:0003074) | 1.83520598 |
| 131 | Type 1 muscle fiber predominance (HP:0003803) | 1.83320992 |
| 132 | Arthropathy (HP:0003040) | 1.82890743 |
| 133 | Hypophosphatemic rickets (HP:0004912) | 1.82720488 |
| 134 | Pulmonary embolism (HP:0002204) | 1.81064545 |
| 135 | Renal cortical cysts (HP:0000803) | 1.81050178 |
| 136 | Abnormal cartilage morphology (HP:0002763) | 1.81016038 |
| 137 | Abnormality of the calf musculature (HP:0001430) | 1.80243296 |
| 138 | Tubulointerstitial abnormality (HP:0001969) | 1.79788864 |
| 139 | Abnormality of the hepatic vasculature (HP:0006707) | 1.79759485 |
| 140 | Elevated hepatic transaminases (HP:0002910) | 1.78771709 |
| 141 | Hydroxyprolinuria (HP:0003080) | 1.78317350 |
| 142 | Abnormality of proline metabolism (HP:0010907) | 1.78317350 |
| 143 | Atrial fibrillation (HP:0005110) | 1.78290763 |
| 144 | Alkalosis (HP:0001948) | 1.77697690 |
| 145 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77481764 |
| 146 | True hermaphroditism (HP:0010459) | 1.77205536 |
| 147 | Decreased circulating renin level (HP:0003351) | 1.76903128 |
| 148 | Spontaneous hematomas (HP:0007420) | 1.75361709 |
| 149 | Oligomenorrhea (HP:0000876) | 1.73855891 |
| 150 | Abnormality of midbrain morphology (HP:0002418) | 1.73217684 |
| 151 | Molar tooth sign on MRI (HP:0002419) | 1.73217684 |
| 152 | Status epilepticus (HP:0002133) | 1.72510735 |
| 153 | Abnormality of vitamin metabolism (HP:0100508) | 1.71989999 |
| 154 | Cerebral palsy (HP:0100021) | 1.71683148 |
| 155 | Hyporeflexia of lower limbs (HP:0002600) | 1.70944178 |
| 156 | Absent speech (HP:0001344) | 1.69372581 |
| 157 | Large for gestational age (HP:0001520) | 1.68413462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.81170185 |
| 2 | SIK1 | 4.62833478 |
| 3 | FGFR4 | 4.39665920 |
| 4 | ERN1 | 3.85474069 |
| 5 | INSRR | 3.26392015 |
| 6 | TAOK3 | 3.09469356 |
| 7 | ERBB4 | 3.05938696 |
| 8 | MAP2K4 | 2.38487565 |
| 9 | MST1R | 2.32481592 |
| 10 | PKN2 | 2.07968646 |
| 11 | PIK3CG | 2.03006848 |
| 12 | ADRBK2 | 2.02032455 |
| 13 | ACVR1B | 1.91167025 |
| 14 | MAPK11 | 1.89162670 |
| 15 | FLT3 | 1.86366519 |
| 16 | BMPR1B | 1.86231167 |
| 17 | DAPK2 | 1.84560256 |
| 18 | MYLK | 1.78298630 |
| 19 | NTRK3 | 1.75249064 |
| 20 | LATS1 | 1.70247541 |
| 21 | FGFR2 | 1.65908883 |
| 22 | FRK | 1.65528526 |
| 23 | NLK | 1.57725470 |
| 24 | MAP4K2 | 1.57443924 |
| 25 | TYK2 | 1.56390365 |
| 26 | TRIB3 | 1.55774525 |
| 27 | TRPM7 | 1.55067449 |
| 28 | NEK9 | 1.48334416 |
| 29 | FER | 1.41331131 |
| 30 | AKT3 | 1.41172715 |
| 31 | PTK6 | 1.37484140 |
| 32 | ABL2 | 1.37056564 |
| 33 | KIT | 1.29778773 |
| 34 | MAP3K7 | 1.28891364 |
| 35 | JAK2 | 1.24841150 |
| 36 | WNK3 | 1.23293439 |
| 37 | KDR | 1.21765363 |
| 38 | PINK1 | 1.19456915 |
| 39 | PRKAA2 | 1.19211284 |
| 40 | ADRBK1 | 1.18723666 |
| 41 | MAPK13 | 1.18189750 |
| 42 | DDR2 | 1.13841757 |
| 43 | PTK2B | 1.13044996 |
| 44 | PHKG1 | 1.12413151 |
| 45 | PHKG2 | 1.12413151 |
| 46 | JAK1 | 1.11481405 |
| 47 | NUAK1 | 1.08778649 |
| 48 | ERBB2 | 1.07640644 |
| 49 | TEC | 1.05840954 |
| 50 | PRKCE | 1.05665787 |
| 51 | MAPKAPK3 | 1.04133084 |
| 52 | MET | 1.01430095 |
| 53 | CAMK1D | 1.01352250 |
| 54 | MAPK4 | 0.98099816 |
| 55 | EPHA3 | 0.97669597 |
| 56 | STK3 | 0.97649732 |
| 57 | TBK1 | 0.95211064 |
| 58 | EPHB1 | 0.94321152 |
| 59 | MAP3K14 | 0.94138922 |
| 60 | CASK | 0.92583924 |
| 61 | MAP3K10 | 0.91374307 |
| 62 | MAP3K4 | 0.90908559 |
| 63 | PRKCZ | 0.89750535 |
| 64 | OXSR1 | 0.86556257 |
| 65 | MAP2K3 | 0.86296294 |
| 66 | BLK | 0.85465962 |
| 67 | GRK6 | 0.84567594 |
| 68 | MAPK15 | 0.82282656 |
| 69 | MAPK12 | 0.80159018 |
| 70 | TIE1 | 0.80156729 |
| 71 | PRKACG | 0.79814566 |
| 72 | CAMK2G | 0.78779859 |
| 73 | STK38L | 0.76643206 |
| 74 | CAMKK2 | 0.75967648 |
| 75 | TGFBR1 | 0.72331298 |
| 76 | PRKG1 | 0.72247033 |
| 77 | STK39 | 0.71698713 |
| 78 | IKBKB | 0.71607712 |
| 79 | SGK3 | 0.71096941 |
| 80 | CSK | 0.70537220 |
| 81 | PRKAA1 | 0.70399548 |
| 82 | RIPK1 | 0.69319761 |
| 83 | CDK6 | 0.68797553 |
| 84 | TGFBR2 | 0.68401183 |
| 85 | ZAK | 0.68247941 |
| 86 | FGFR3 | 0.67641045 |
| 87 | GSK3A | 0.67330276 |
| 88 | MUSK | 0.66128937 |
| 89 | MAP3K3 | 0.65466813 |
| 90 | TNIK | 0.64446731 |
| 91 | EIF2AK3 | 0.62020745 |
| 92 | DYRK1B | 0.59896272 |
| 93 | CSF1R | 0.59148065 |
| 94 | MAPK7 | 0.59016974 |
| 95 | PRKACA | 0.58773494 |
| 96 | CAMK1 | 0.58364851 |
| 97 | PKN1 | 0.58273301 |
| 98 | MARK1 | 0.57001308 |
| 99 | MAP3K11 | 0.56801782 |
| 100 | RET | 0.56801479 |
| 101 | GRK5 | 0.56223225 |
| 102 | CDC42BPA | 0.55957867 |
| 103 | PDPK1 | 0.54549708 |
| 104 | MAP2K6 | 0.54178175 |
| 105 | PRKD1 | 0.54084917 |
| 106 | SGK2 | 0.54059483 |
| 107 | PRKCQ | 0.51459428 |
| 108 | IGF1R | 0.50925800 |
| 109 | TNK2 | 0.50852108 |
| 110 | CAMK2A | 0.50833936 |
| 111 | GRK1 | 0.50247942 |
| 112 | TXK | 0.49980478 |
| 113 | MAP2K1 | 0.49518043 |
| 114 | IKBKE | 0.49438975 |
| 115 | CAMK1G | 0.49291668 |
| 116 | CHUK | 0.49287931 |
| 117 | PTK2 | 0.49093231 |
| 118 | PDGFRB | 0.48722314 |
| 119 | PIK3CA | 0.48404523 |
| 120 | GRK7 | 0.47292663 |
| 121 | STK11 | 0.47253010 |
| 122 | IRAK3 | 0.47197400 |
| 123 | CSNK1G1 | 0.44558724 |
| 124 | ABL1 | 0.44300438 |
| 125 | SGK223 | 0.42930906 |
| 126 | SGK494 | 0.42930906 |
| 127 | SYK | 0.42862871 |
| 128 | ITK | 0.42653478 |
| 129 | MAP3K5 | 0.42636785 |
| 130 | PRKCG | 0.41266786 |
| 131 | LATS2 | 0.41095051 |
| 132 | STK38 | 0.39651955 |
| 133 | MAP3K13 | 0.39252027 |
| 134 | BMPR2 | 0.37861678 |
| 135 | PDK3 | 0.36952991 |
| 136 | PDK4 | 0.36952991 |
| 137 | PDK1 | 0.36805043 |
| 138 | MAP3K6 | 0.36703078 |
| 139 | EPHA4 | 0.36656497 |
| 140 | EGFR | 0.36215922 |
| 141 | MTOR | 0.36002871 |
| 142 | PDK2 | 0.35233072 |
| 143 | MELK | 0.35126487 |
| 144 | ROCK1 | 0.34919723 |
| 145 | ICK | 0.34477788 |
| 146 | RPS6KA3 | 0.34283871 |
| 147 | MAP3K1 | 0.33330085 |
| 148 | CAMK4 | 0.33234098 |
| 149 | PAK3 | 0.33023815 |
| 150 | TAOK2 | 0.31866804 |
| 151 | IRAK1 | 0.30130988 |
| 152 | MAP3K2 | 0.28751776 |
| 153 | PDGFRA | 0.28462599 |
| 154 | PRKCA | 0.26996311 |
| 155 | OBSCN | 0.26597123 |
| 156 | CSNK1G2 | 0.26268242 |
| 157 | PRKACB | 0.24974827 |
| 158 | IRAK2 | 0.24850797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55987385 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.78758511 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37035254 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32389200 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07773883 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83186230 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70985414 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69251103 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56322482 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50898401 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49822401 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38055688 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21907437 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16714885 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14067296 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06751081 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96300883 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96098749 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93774215 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90427786 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90307487 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89532030 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83296328 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79898546 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75310439 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75045574 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73772760 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71767780 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69601304 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65379227 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55375384 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54284086 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52885543 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.50577122 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47682430 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45922585 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44040297 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35728711 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35208856 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31423741 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27301777 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25567800 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18162632 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18151421 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16695063 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12828246 |
| 47 | * ABC transporters_Homo sapiens_hsa02010 | 1.12590869 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11455920 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03221217 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98162423 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97996252 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94881667 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93714779 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91039726 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87015996 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86834969 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85067258 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83142803 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81149928 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74028879 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70342112 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69439510 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69235502 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66832027 |
| 65 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66259506 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65111919 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62094032 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61196475 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61056219 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.55464401 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54162287 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51765763 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49714083 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49594861 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49095358 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47984897 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44981044 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44312149 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43766823 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.41875502 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41326479 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.40036885 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37501147 |
| 84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35320262 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.32592980 |
| 86 | Insulin secretion_Homo sapiens_hsa04911 | 0.32355648 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.30641730 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.30483041 |
| 89 | Salivary secretion_Homo sapiens_hsa04970 | 0.28312794 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.28290520 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.27879220 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.26577183 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.26569204 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.26094378 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25538672 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.24845176 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24380335 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23993759 |
| 99 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.23406346 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23351180 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20988641 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.20191246 |
| 103 | GABAergic synapse_Homo sapiens_hsa04727 | 0.19859082 |
| 104 | Taste transduction_Homo sapiens_hsa04742 | 0.19193342 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18718028 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18040287 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.17783391 |
| 108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17578466 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.17070894 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16756874 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15089912 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13458379 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03559622 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2289398 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | -0.2286794 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2180962 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2176007 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2175959 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2124343 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | -0.1962172 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1813735 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | -0.1784480 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1780698 |
| 124 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1765134 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1515180 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1504753 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1472960 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1408118 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1334778 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0936760 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0622047 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0606676 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0489797 |
| 134 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0380660 |

